₹1100.0
+0.27% today
· 30d +0.92%
as of 2026-09-04
Price · Daily Candles
“TTK Healthcare: DIIs increase stake as Q4 profits plunge, stock eyes 52-week lows.”
TTK Healthcare's Q4 2025 net profit plummeted by 37.05% YoY to ₹11 Cr, despite a modest 2.22% revenue increase to ₹209 Cr. This sharp profit decline comes alongside a -30.2% price return over the past year, reflecting market concerns. However, domestic institutions appear optimistic, increasing their stake by 0.03% QoQ to 1.11%.
BULL CASE
+Despite recent price weakness, TTK Healthcare has demonstrated robust long-term profit growth with a 5-year Net Profit CAGR of 45.98%.
+Promoter shareholding remains strong at 74.56%, indicating high confidence in management.
+DIIs increased their stake by 0.03% QoQ, now holding 1.11% of the company.
+The company's PE TTM of 20.69 is significantly lower than some peers like GLAXO (37.32) and RUBICON (119.89).
BEAR CASE
−Q4 2025 net profit saw a significant YoY decline of 37.05% to ₹11 Cr.
−The stock has shed 30.2% over the last year and is trading 37.65% off its 52-week high of ₹1398.9.
−Quarterly operating profit in Q4 2025 decreased by 3.75% YoY to ₹25 Cr.
−The ML prediction for ebit stable 7y growth is neutral to weak, with a rank of 0.504.
⟳ What Changed
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹258 Cr
+13.75% YoY
NET PROFIT
₹21 Cr
+63.69% YoY
OPM
11.49%
+3.06pp YoY
EPS
₹15.06
PE 20.69
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-1.7% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
TTK Healthcare trades at a TTM PE of 20.69, positioning it below industry leaders like GLAXO (37.32 PE) and PFIZER (29.39 PE), while its ROCE is not provided for direct comparison.
PEERPEROCE %
TTKHLTCARE20.69—
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒
55
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
NEUTRAL
40
Valuation
REASONABLE
60
Growth
MUTED
38
Profitability
DECENT
55
Technicals
NEUTRAL
67
Risk
LOW
70
Key Stats
TTM PE
20.69
P/B
1.15
52W HIGH
₹1216.8
OFF HIGH
-9.6%
DIV YIELD
1.13%
MKT CAP
₹1568 Cr
◉ Active Signals
MACDNeutral-4.7894
RSI(14)Neutral52.79
⧉ Strategy Fit 🔒